CARL (Carlsmed) Net Profit

Corporate emblem and logo of carlsmed.com (CARL)

The price trajectory for Carlsmed Inc (CARL) shown below reflects the dynamics of a company that enjoys immense trust from surgeons due to its creation of unique AI solutions for the spine. The business relies on a protected medical segment where demand is independent of economic cycles and success is driven by technological progress. The current indicator stands at -0.04, confirming the issuer's status as a leading developer of personalized implants.

CARL: Carlsmed Inc Net Profit 07/24/2025 - 11/01/2026

Financial and market metric breakdowns for Carlsmed (CARL)

- current quotes and average value forecast:
Market Chart Carlsmed Medical|CARL - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Carlsmed Medical|CARL - Total Company Value
- book capitalization data:
Net Assets per Single Share Carlsmed|CARL - Book Capitalization|Market Capitalization to Book Value carlsmed.com|CARL - Cumulative Company Assets
- debt and liquidity details:
Aggregate Debt to Equity Carlsmed Inc|CARL - Long-Term Debt to Capital|Current Liabilities to Capital Carlsmed, Inc.|CARL - Company Aggregate Debts|Debt to Book Value Ratio Carlsmed Medical|CARL - Company Long-Term Liabilities|Company Short-Term Loans and Borrowings Carlsmed|Quick Liquidity Indicator carlsmed.com
- earnings and valuation multiples information:
CARL - Net Profit
Fundamental valuation:Carlsmed Medical
Product sample of Carlsmed Inc

AI implant shipments from Carlsmed Inc. drive the company's profit dynamics on the GURU.Markets platform. An analysis of daily net earnings reveals consolidation phases and the business's resilience to market shocks. The daily calculation of financial results serves as a strict indicator of the asset's current liquidity. False breakouts in yield signal the risk of overpaying for exhausted potential. This metric characterizes the securities as a high-tech investment instrument.

Key competitors

BSX - Net Financial Result|EW (Edwards Lifesciences) - Net Profit|Net Profit resmed.com|Company Net Income Insulet (PODD)|Company Net Income ZBH (Zimmer Biomet Holdings)|Net Profit COO (CooperVision)|Net Financial Result Align Corp (ALGN)|GMED: Net Income|Profit After Tax TMDX|ATEC: Net Profit|Company Net Income CryoLife (AORT)|ENOV (DJO Global) - Net Profit|Company Profit IART (Integra LifeSciences Inc.)|Net Income ESTA (Establishment Labs)|BBNX (betabionics.com) - Final Profit|Company Net Income IRADIMED IRMD|EMBC - Net Income|Tandem Diabetes - Net Profit|Company Net Income Axogen Surgical|SIBN: Net Profit|Company Profit OFIX|BVS (Bioventus) - Net Profit|OrthoPediatrics Inc. (KIDS) - Net Financial Result|Net Profit TMCI|Net Income Strata Medical SRTA|Net Profit RXST (RxSight, Inc.)|Net Profit ClearPoint Neuro Inc. CLPT|STXS - Company Net Income|STIM: Company Net Income|SGHT (Sight Sciences, Inc) - Net Income|Orchestra BioMed Inc. - Final Profit|ANIK (Anika Therapeutics Inc.) - Net Profit|Company Net Income inspiremd.com NSPR|Company Net Income Jin Medical International (ZJYL)|vivani.com (VANI) - Annual Net Income|Xtant Medical - Net Income|Net Profit NeuroOne Medical Technologies Corp. NMTC|Modular Med - Net Profit|Net Financial Result myomo.com MYO|Envoy Medical (COCH) - Company Net Income|Profit After Tax VVOS (Vivos Therapeutics Inc.)|Company Net Income enVVeno|Net Income SINTX Technologies (SINT)|Net Profit TNON|LFWD - Company Net Income|Company Net Income Autonomix Medical AMIX|IVF: Company Profit|BBLG: Net Income|Axonics, Inc - Profit After Payment of Taxes|BIOL: Net Profit|Net Income Dynatronics|FNA (Paragon 28 Inc.) - Net Profit|Net Profit INVO Bio